Skip to content

Sound Therapy for Tinnitus Relief in Cochlear Implant Users

Cochlear Active Relief From Tinnitus (CART) Sound Therapy for Tinnitus Relief in Nucleus® Cochlear Implant Users With Tinnitus

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03026829
Enrollment
32
Registered
2017-01-20
Start date
2017-10-03
Completion date
2019-01-24
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus, Hearing Loss, Cochlear Implant Users

Keywords

Sound therapy, Tinnitus relief

Brief summary

The aim of this exploratory study is to evaluate the use and effectiveness of sound therapy for tinnitus relief in cochlear implant users with tinnitus. The sound therapy is a combination of tinnitus counselling and sound enrichment with the Cochlear Active Relief from Tinnitus (CART) firmware.

Interventions

DEVICECART sound therapy

The study consists of two parts: Phase 1: laboratory evaluation of CART sound acceptability Phase 2: take home evaluation of CART sound therapy including baseline without CART

Sponsors

Cochlear
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Self-reported tinnitus during standard Cochlear Implant (CI) activation for at least one month * At least three months use of unilateral or bilateral Nucleus CI(s) driven by a CP900 Sound Processor. For bilateral use the most recently activated CI is used for at least three months * Native speaker and fluency in the language used in the assessments (i.e. Dutch)

Exclusion criteria

* Additional handicaps that would prevent participation in evaluations * History of psychiatric disorders or depression (on investigator's opinion) * Unrealistic expectations as identified by the clinician on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the study * Pulsatile or diagnosed objective / middle ear tinnitus

Design outcomes

Primary

MeasureTime frameDescription
Quantification of Cochlear Implant (CI) patient's tinnitus via Visual Analogue Scale (VAS)week 0Visual Analogue Scale (VAS) score on tinnitus
Quantification of Cochlear Implant (CI) patient's tinnitus via Tinnitus Functional Index (TFI)week 0

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026